0
Amplia Therapeutics Banner Image

Amplia Therapeutics

  • Ticker ATX
    Exchange ASX More
  • Industry Biotechnology More
  • Sector Healthcare More
Amplia Therapeutics Logo Image
  • 1-10 Employees
  • Based in Melbourne, Australia
Amplia Therapeutics Limited is a pharmaceutical company advancing a pipeline of FAK inhibitors for cancer and fibrosis. The lead molecule, AMP945, is a “pure play” inhibitor with superior specificity.
REPORT RATINGS
4.8 / 5.0 (53)

Amplia Therapeutics reports have an aggregate usefulness score of 4.8 based on 53 reviews.

Amplia Therapeutics

Most Recent Annual Report

Amplia Therapeutics
MOST RECENT 2022 Annual Report

Older/Archived Annual Reports

Amplia Therapeutics Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!